BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:d6541151-199b-4d7d-ad04-a113b72cf56a
DTSTAMP:20250617T153826
DTSTART:20250922T100000
DTEND:20250922T110000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:3d51533d-0185-41b1-a434-1f0d8a671aa8
DTSTAMP:20250617T153826
DTSTART:20250922T110000
DTEND:20250922T120000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:bdc69d27-d131-4293-b95a-be9ff4be7b5f
DTSTAMP:20250617T153826
DTSTART:20250925T100000
DTEND:20250925T110000
SUMMARY:Labcoat collection (9-10)
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:025dfc58-2bb0-4143-ab25-1f2aca131aaf
DTSTAMP:20250617T153826
DTSTART:20250926T100000
DTEND:20250926T110000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:2e06cf06-a8ce-4681-b1e0-72197467f355
DTSTAMP:20250617T153826
DTSTART:20250926T110000
DTEND:20250926T120000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:7110e375-81b0-483e-96ed-5b5a4df6c3f1
DTSTAMP:20250617T153826
DTSTART:20250926T120000
DTEND:20250926T130000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:eeb8f137-a37b-4bd2-8a48-c4101f5344f5
DTSTAMP:20250617T153826
DTSTART:20250926T140000
DTEND:20250926T150000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:96558148-a116-493c-af0e-54bd2382fe03
DTSTAMP:20250617T153826
DTSTART:20250926T150000
DTEND:20250926T160000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:85f178ad-568d-48b0-a329-3de907694318
DTSTAMP:20250617T153826
DTSTART:20250929T110000
DTEND:20250929T120000
SUMMARY:Skills Introduction to module
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d805cc18-e0a5-45f5-b71a-24c08897c624
DTSTAMP:20250617T153826
DTSTART:20250929T120000
DTEND:20250929T130000
SUMMARY:Introduction to FS and pharmacodynamics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:47986508-18ca-4e09-a73b-68d1688cb432
DTSTAMP:20250617T153826
DTSTART:20250929T140000
DTEND:20250929T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f135ad90-c5e3-421e-a3cd-b0db745a1325
DTSTAMP:20250617T153826
DTSTART:20250929T150000
DTEND:20250929T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fbd1524f-0c7e-41d6-8763-3fb69b88f06c
DTSTAMP:20250617T153826
DTSTART:20250930T100000
DTEND:20250930T110000
SUMMARY:FS 1.1 The Body: Introduction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:36be25ea-834f-4942-bc5f-67f8f419e458
DTSTAMP:20250617T153826
DTSTART:20250930T110000
DTEND:20250930T120000
SUMMARY:FS 1.2 The Body: Tissues
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1287749f-aae7-48d5-9f9c-ccffb713fbf5
DTSTAMP:20250617T153826
DTSTART:20250930T120000
DTEND:20250930T130000
SUMMARY:FS 1.3 The Body: Cells and Molecules
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:2773c0fe-8c24-4d98-8dea-e37ff3757272
DTSTAMP:20250617T153826
DTSTART:20250930T140000
DTEND:20250930T150000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dad501a2-6e84-43c1-a88d-d15b2d62fd77
DTSTAMP:20250617T153826
DTSTART:20250930T150000
DTEND:20250930T160000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0f92a169-340e-4986-92e1-52d3449c68d5
DTSTAMP:20250617T153826
DTSTART:20251002T110000
DTEND:20251002T120000
SUMMARY:PD 1.1 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:3e52b361-777b-47a5-b40c-a2619bdb4821
DTSTAMP:20250617T153826
DTSTART:20251002T120000
DTEND:20251002T130000
SUMMARY:PD 1.2 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:f3ab41b2-0ae6-4f99-951a-be234d374ada
DTSTAMP:20250617T153826
DTSTART:20251002T140000
DTEND:20251002T150000
SUMMARY:DS 1.1 Introduction to data and statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:d8dff543-7e7c-416d-9f18-131a67adc96f
DTSTAMP:20250617T153826
DTSTART:20251002T150000
DTEND:20251002T160000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:cae845f8-edeb-4d02-b810-02d5d61773ce
DTSTAMP:20250617T153826
DTSTART:20251002T160000
DTEND:20251002T170000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:0c958a4a-15ec-4d4a-a4ac-f962edd7ad23
DTSTAMP:20250617T153826
DTSTART:20251003T140000
DTEND:20251003T150000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:5f0cb756-be42-4a11-83ae-cdd226b24a66
DTSTAMP:20250617T153826
DTSTART:20251003T150000
DTEND:20251003T160000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:53bca69f-ea73-4196-b22e-90b91e39dcfa
DTSTAMP:20250617T153826
DTSTART:20251006T100000
DTEND:20251006T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b8443353-3349-4fe2-a29b-d78b305c8263
DTSTAMP:20250617T153826
DTSTART:20251006T110000
DTEND:20251006T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9d3b992b-9e7d-44f9-abc7-c0742a4b6132
DTSTAMP:20250617T153826
DTSTART:20251006T120000
DTEND:20251006T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c7886d99-a825-4ee0-9035-3f07b4614bfd
DTSTAMP:20250617T153826
DTSTART:20251006T140000
DTEND:20251006T150000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7037be14-5ebb-427c-8049-0fc51498863e
DTSTAMP:20250617T153826
DTSTART:20251006T150000
DTEND:20251006T160000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9647e39e-6376-4b1a-ab65-1ea49263a6d3
DTSTAMP:20250617T153826
DTSTART:20251006T160000
DTEND:20251006T170000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9497da08-c302-4bf5-871d-f2b83b3d2cd6
DTSTAMP:20250617T153826
DTSTART:20251007T110000
DTEND:20251007T120000
SUMMARY:FS 1.4 The Body: Control and Regulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:69b2dc38-c1d2-4ff4-ada9-3944b7cf7808
DTSTAMP:20250617T153826
DTSTART:20251007T120000
DTEND:20251007T130000
SUMMARY:FS 1.5 The Body: Environment and Exchange
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:38dad67e-0c8c-4228-9d06-bcf5d510c486
DTSTAMP:20250617T153826
DTSTART:20251007T140000
DTEND:20251007T150000
SUMMARY:FS 1.6 The Body: Growth and Energy
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:57df44ca-5d01-432c-b50b-7ba8226ba819
DTSTAMP:20250617T153826
DTSTART:20251009T110000
DTEND:20251009T120000
SUMMARY:PD 1.3 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:89fe8c2a-6ff4-4ac8-96e3-e4e2465eee36
DTSTAMP:20250617T153826
DTSTART:20251009T120000
DTEND:20251009T130000
SUMMARY:PD 1.4 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:f79f591f-f97b-4f29-9859-5ac5e26f345b
DTSTAMP:20250617T153826
DTSTART:20251009T140000
DTEND:20251009T150000
SUMMARY:DS 1.2 Types of data and how to describe them
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:c5a0e5bc-d09f-40f5-9d2f-811533ce026c
DTSTAMP:20250617T153826
DTSTART:20251009T150000
DTEND:20251009T160000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:f5f8c0af-e6d2-453a-89e6-2fb8141d2cc5
DTSTAMP:20250617T153826
DTSTART:20251009T160000
DTEND:20251009T170000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:832879a5-5650-4427-8ccd-2118305f9b06
DTSTAMP:20250617T153826
DTSTART:20251010T100000
DTEND:20251010T110000
SUMMARY:DD Introduction to drug development
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:bfc78f34-2459-4a43-8910-97373fee8c3c
DTSTAMP:20250617T153826
DTSTART:20251010T110000
DTEND:20251010T120000
SUMMARY:DD Introduction to biomedical research and bias
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:8b0e0e7a-c0fe-4ade-a58d-4ed7e4af334d
DTSTAMP:20250617T153826
DTSTART:20251010T120000
DTEND:20251010T130000
SUMMARY:Comms Introduction to the library
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a61fdaa2-87c1-452f-aba2-12d429088a05
DTSTAMP:20250617T153826
DTSTART:20251010T140000
DTEND:20251010T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:4e13baea-13e4-4271-89f9-fde434989304
DTSTAMP:20250617T153826
DTSTART:20251010T150000
DTEND:20251010T160000
SUMMARY:Skills WINDEC and hand hygiene [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:82c6ea82-9574-4558-8020-8855ab22fd62
DTSTAMP:20250617T153826
DTSTART:20251013T100000
DTEND:20251013T110000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7a31c598-6f4d-4f03-8d7e-bd08328a597a
DTSTAMP:20250617T153826
DTSTART:20251013T110000
DTEND:20251013T120000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dcf896b9-8a73-480b-bdf4-518bb65ed3b8
DTSTAMP:20250617T153826
DTSTART:20251013T120000
DTEND:20251013T130000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d7dbfdc1-06c9-4ee7-bb1a-3efa961857e9
DTSTAMP:20250617T153826
DTSTART:20251013T140000
DTEND:20251013T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:23ea12f3-595e-4f30-96a0-114d01860f22
DTSTAMP:20250617T153826
DTSTART:20251013T150000
DTEND:20251013T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b6ba9fec-b7bc-421e-9ba2-6a41eb348e64
DTSTAMP:20250617T153826
DTSTART:20251014T100000
DTEND:20251014T110000
SUMMARY:FS 1.7 Chemical Mediators
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:9e896228-7a44-467c-9b3b-d3dac41c77ee
DTSTAMP:20250617T153826
DTSTART:20251014T110000
DTEND:20251014T120000
SUMMARY:FS 1.8 Cell division and fate
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8f7cb750-2f7e-4d19-84f1-f362a1a83bf3
DTSTAMP:20250617T153826
DTSTART:20251014T120000
DTEND:20251014T130000
SUMMARY:FS 1.9 DNA to Gene Expression
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:b3c5e221-3d94-43f1-ab6b-c6b1164d6f55
DTSTAMP:20250617T153826
DTSTART:20251015T100000
DTEND:20251015T110000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c2a8162d-beb0-498f-8086-49c116ac6d2d
DTSTAMP:20250617T153826
DTSTART:20251015T110000
DTEND:20251015T120000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9f0aaf12-1afa-410d-8092-2b6e97675c24
DTSTAMP:20250617T153826
DTSTART:20251016T100000
DTEND:20251016T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:fe054818-ab03-451e-bd6a-e41558217d93
DTSTAMP:20250617T153826
DTSTART:20251016T110000
DTEND:20251016T120000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1b4fd6ca-5834-46d3-8131-d4ab023b14b6
DTSTAMP:20250617T153826
DTSTART:20251016T120000
DTEND:20251016T130000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5241454a-39c0-45e4-a686-52e4343494c7
DTSTAMP:20250617T153826
DTSTART:20251016T140000
DTEND:20251016T150000
SUMMARY:PD 1.5 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:5f3093bb-4c36-4561-a6a8-b0316eb53fa8
DTSTAMP:20250617T153826
DTSTART:20251016T150000
DTEND:20251016T160000
SUMMARY:PD 1.6 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:651872d4-2f10-4564-a79e-8ec0b2b45177
DTSTAMP:20250617T153826
DTSTART:20251017T110000
DTEND:20251017T120000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:ba9a96b3-dbbd-4a18-bf69-306250c66dd4
DTSTAMP:20250617T153826
DTSTART:20251017T120000
DTEND:20251017T130000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:7f327685-4e66-40a3-9f77-eaaa25098883
DTSTAMP:20250617T153826
DTSTART:20251017T140000
DTEND:20251017T150000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:9926bd86-3a4f-4784-85a1-23cb0281cf8e
DTSTAMP:20250617T153826
DTSTART:20251017T150000
DTEND:20251017T160000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:ba3fee3f-7e20-4fa4-8e3f-8e5248cf4c17
DTSTAMP:20250617T153826
DTSTART:20251020T100000
DTEND:20251020T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:074ede15-5eb6-4017-8405-3b05b153173d
DTSTAMP:20250617T153826
DTSTART:20251020T110000
DTEND:20251020T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:af456399-28cd-42ef-9e9c-d62d58c9752f
DTSTAMP:20250617T153826
DTSTART:20251020T120000
DTEND:20251020T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a5fdda1c-53f3-4c89-a93b-f769749d31de
DTSTAMP:20250617T153826
DTSTART:20251020T140000
DTEND:20251020T150000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b7b25b45-7c6c-43cf-94db-4410c0419267
DTSTAMP:20250617T153826
DTSTART:20251020T150000
DTEND:20251020T160000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cce0b220-aff3-459a-9315-b3c182721413
DTSTAMP:20250617T153826
DTSTART:20251020T160000
DTEND:20251020T170000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8c7aac85-a973-4d83-986d-c759269f5c42
DTSTAMP:20250617T153826
DTSTART:20251021T110000
DTEND:20251021T120000
SUMMARY:DD Target selection and validation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:720157e4-929a-429c-b8d6-435672cef139
DTSTAMP:20250617T153826
DTSTART:20251021T120000
DTEND:20251021T130000
SUMMARY:DD  Lead generation and optimisation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:b6bef427-ef2b-4c09-8199-add599d40515
DTSTAMP:20250617T153826
DTSTART:20251021T140000
DTEND:20251021T150000
SUMMARY:FS 1.10 G protein coupled receptors
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:78312582-0b86-45cd-a844-434e82f2ab12
DTSTAMP:20250617T153826
DTSTART:20251021T150000
DTEND:20251021T160000
SUMMARY:FS 1.11 Membrane Potentials and Action Potentials
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:fca76eb8-485e-4449-8315-d907fb9746bd
DTSTAMP:20250617T153826
DTSTART:20251023T100000
DTEND:20251023T110000
SUMMARY:Skills Routes of administration [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a983b023-83b8-4de3-881b-dbb50391c431
DTSTAMP:20250617T153826
DTSTART:20251023T110000
DTEND:20251023T120000
SUMMARY:FS 1.12 Autonomic nervous system 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c0b147dc-17a2-48e6-8eb9-19fecbacdcd9
DTSTAMP:20250617T153826
DTSTART:20251023T120000
DTEND:20251023T130000
SUMMARY:FS 1.13 Autonomic nervous system 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:6fdd254e-0fea-438f-aca0-4c70f492af17
DTSTAMP:20250617T153826
DTSTART:20251023T140000
DTEND:20251023T150000
SUMMARY:DS 1.3  Introduction to clinical study design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7b973d4f-cef8-4af4-824c-a29bc4da1818
DTSTAMP:20250617T153826
DTSTART:20251023T150000
DTEND:20251023T160000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:286935ba-9360-4230-8510-a6ca1e4d3f8d
DTSTAMP:20250617T153826
DTSTART:20251023T160000
DTEND:20251023T170000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:86dbc500-d44a-4db8-822e-bc2a064e8bf5
DTSTAMP:20250617T153826
DTSTART:20251024T110000
DTEND:20251024T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:1d8aabd6-241e-4558-8ba1-30fb91263ae7
DTSTAMP:20250617T153826
DTSTART:20251024T120000
DTEND:20251024T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:a6e8af20-739c-4a8a-ae59-4cde1cba146b
DTSTAMP:20250617T153826
DTSTART:20251024T130000
DTEND:20251024T140000
SUMMARY:WEC Lunch and learn
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d6e4b40c-c455-4cab-b3d0-0990637d913c
DTSTAMP:20250617T153826
DTSTART:20251024T140000
DTEND:20251024T150000
SUMMARY:PD 1.7 Drugs targeting ANS -Part 1:  Sympathetic/Parasympathetic GPCRs
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:29369c8c-43a2-4e89-8e11-75bcdd806783
DTSTAMP:20250617T153826
DTSTART:20251024T150000
DTEND:20251024T160000
SUMMARY:DH 1.4  How drugs are used in hospitals
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:ae1dfa34-f104-4033-a0e2-32297fc69c8b
DTSTAMP:20250617T153826
DTSTART:20251027T100000
DTEND:20251027T110000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:69b11a23-da4f-4419-99c7-b9b0c31aed2f
DTSTAMP:20250617T153826
DTSTART:20251027T110000
DTEND:20251027T120000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:40bff3e7-455d-4002-9042-b2bdece80984
DTSTAMP:20250617T153826
DTSTART:20251027T120000
DTEND:20251027T130000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4e18639e-cbc7-4dd1-8b98-b1c08da69f1e
DTSTAMP:20250617T153826
DTSTART:20251027T140000
DTEND:20251027T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6aa80283-6f2f-4d8a-9c90-5583e2084ee4
DTSTAMP:20250617T153826
DTSTART:20251027T150000
DTEND:20251027T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3642c1c1-0677-4353-a9f0-0cd3064eea1b
DTSTAMP:20250617T153826
DTSTART:20251028T110000
DTEND:20251028T120000
SUMMARY:FS 1.16 Excitable Cells
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:744583b4-8724-470d-8036-8440dc5e187e
DTSTAMP:20250617T153826
DTSTART:20251030T110000
DTEND:20251030T120000
SUMMARY:FS 1.14 Ion Channels
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:718024f4-dedb-4eac-b1b6-4af569e940a7
DTSTAMP:20250617T153826
DTSTART:20251030T120000
DTEND:20251030T130000
SUMMARY:FS 1.15  LGICRs
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c1247fce-dd0c-4333-8581-c1ce6c393d60
DTSTAMP:20250617T153826
DTSTART:20251030T140000
DTEND:20251030T150000
SUMMARY:PD 1.8 Drugs targenting ANS Part II - ANS scenarios
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:7b6652c3-8261-4788-a00a-4bb35a4f363e
DTSTAMP:20250617T153826
DTSTART:20251030T150000
DTEND:20251030T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:b1b494c2-e054-4036-bddf-8f82fb057821
DTSTAMP:20250617T153826
DTSTART:20251031T100000
DTEND:20251031T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dfe79347-f467-4e2b-b2db-a795a100d8cb
DTSTAMP:20250617T153826
DTSTART:20251031T110000
DTEND:20251031T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:5288166e-711c-4fb7-830c-8f444d9afc78
DTSTAMP:20250617T153826
DTSTART:20251031T140000
DTEND:20251031T150000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f79917ad-db42-4291-85de-527ac48a2953
DTSTAMP:20250617T153826
DTSTART:20251031T150000
DTEND:20251031T160000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2615dc34-5d02-4859-a47c-a65ada3c69dd
DTSTAMP:20250617T153826
DTSTART:20251103T100000
DTEND:20251103T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d55af13c-e7f4-4010-9159-c33fd7b7b9ab
DTSTAMP:20250617T153826
DTSTART:20251103T110000
DTEND:20251103T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8eaeed2a-c2bc-4621-a4d5-67c8ac15f8d1
DTSTAMP:20250617T153826
DTSTART:20251103T120000
DTEND:20251103T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:58e674fc-caa7-423f-a51e-5554c93df6e7
DTSTAMP:20250617T153826
DTSTART:20251103T140000
DTEND:20251103T150000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:99dcb2d7-16e8-47ea-88be-9c19dff7f81c
DTSTAMP:20250617T153826
DTSTART:20251103T150000
DTEND:20251103T160000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1d618937-7690-4d13-bfb9-fa3c18fec3c2
DTSTAMP:20250617T153826
DTSTART:20251103T160000
DTEND:20251103T170000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:411b2ac1-61dc-4027-9ddf-9ac80628b9b9
DTSTAMP:20250617T153826
DTSTART:20251104T110000
DTEND:20251104T120000
SUMMARY:FS 1.17 Skeletal muscle contraction and NMJ
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f683b23e-3f10-405b-948a-7bb0e148bf74
DTSTAMP:20250617T153826
DTSTART:20251104T120000
DTEND:20251104T130000
SUMMARY:FS 1.18 Smooth muscle contraction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:748b86fb-4615-441c-a4b8-08ef5c00d2fe
DTSTAMP:20250617T153826
DTSTART:20251104T140000
DTEND:20251104T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:26d7af66-c909-44cc-be97-8d50fd22d837
DTSTAMP:20250617T153826
DTSTART:20251104T150000
DTEND:20251104T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:73b247ff-aabc-4fbc-9c01-1eb6c1a31e00
DTSTAMP:20250617T153826
DTSTART:20251105T100000
DTEND:20251105T110000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a5ea77b5-ac0e-4b61-a336-b967127c0523
DTSTAMP:20250617T153826
DTSTART:20251105T110000
DTEND:20251105T120000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3bdcf75d-5514-45c4-87b5-225d56bde4d4
DTSTAMP:20250617T153826
DTSTART:20251106T110000
DTEND:20251106T120000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c6b002f3-d3a8-407c-9926-8688d2a61533
DTSTAMP:20250617T153826
DTSTART:20251106T120000
DTEND:20251106T130000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:d7738f23-44da-4d10-bc49-581d4eb59c49
DTSTAMP:20250617T153826
DTSTART:20251106T140000
DTEND:20251106T150000
SUMMARY:DS 1.4 Hypothesis testing
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:12cd74df-618e-4727-941f-c7d0892d8dd2
DTSTAMP:20250617T153826
DTSTART:20251106T150000
DTEND:20251106T160000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:c161e526-6eb2-4102-b81e-91212688aa02
DTSTAMP:20250617T153826
DTSTART:20251106T160000
DTEND:20251106T170000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:f8c18f8c-a64d-4415-837f-2aa5cd51a216
DTSTAMP:20250617T153826
DTSTART:20251107T100000
DTEND:20251107T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7fd512a7-8b2a-439b-8a0c-990dea4dce23
DTSTAMP:20250617T153826
DTSTART:20251107T110000
DTEND:20251107T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:a3f88bd2-888e-4878-afb3-7f5cb08800b7
DTSTAMP:20250617T153826
DTSTART:20251107T140000
DTEND:20251107T150000
SUMMARY:DD Introduction to clinical trials
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:1999e73f-f0a0-4191-b99b-5bccf18dd8d7
DTSTAMP:20250617T153826
DTSTART:20251107T150000
DTEND:20251107T160000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:9e8cf23f-bda3-4d0c-bb8f-0ba8337580d5
DTSTAMP:20250617T153826
DTSTART:20251107T160000
DTEND:20251107T170000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:da8044dd-de69-42f4-a7ff-055962b74cf5
DTSTAMP:20250617T153826
DTSTART:20251110T100000
DTEND:20251110T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:04a8f079-043c-4d64-a108-96a71075d04d
DTSTAMP:20250617T153826
DTSTART:20251110T110000
DTEND:20251110T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6b4b76df-27e3-4635-a6b5-d063ed236156
DTSTAMP:20250617T153826
DTSTART:20251110T120000
DTEND:20251110T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:03847090-0acf-4229-830a-ec521e4e1599
DTSTAMP:20250617T153826
DTSTART:20251110T140000
DTEND:20251110T150000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2d82f0dc-7b7b-4d75-8c31-0cd480befab7
DTSTAMP:20250617T153826
DTSTART:20251110T150000
DTEND:20251110T160000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:968d4a74-d664-4c9f-bbd8-5c75dc799b77
DTSTAMP:20250617T153826
DTSTART:20251111T120000
DTEND:20251111T130000
SUMMARY:Skills Measuring vital signs [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b301c0c1-7015-4b6e-9be6-ee02dc581dc0
DTSTAMP:20250617T153826
DTSTART:20251111T130000
DTEND:20251111T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:d9ced19b-e347-496a-8a60-74527e4fa827
DTSTAMP:20250617T153826
DTSTART:20251111T140000
DTEND:20251111T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:85e0f421-d57b-4996-bfdf-479f57fd962b
DTSTAMP:20250617T153826
DTSTART:20251112T100000
DTEND:20251112T110000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cae110bb-724a-40e4-a477-9cc47b1b5827
DTSTAMP:20250617T153826
DTSTART:20251112T110000
DTEND:20251112T120000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4a0c8c53-396a-4f50-b6bc-11e15a2a596a
DTSTAMP:20250617T153826
DTSTART:20251113T100000
DTEND:20251113T110000
SUMMARY:Comms Course director/year lead check in 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:339d93bb-b11e-4532-b456-2b8026102ef4
DTSTAMP:20250617T153826
DTSTART:20251113T110000
DTEND:20251113T120000
SUMMARY:FS 1.19 Body compartments and biological barriers 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:086a2d94-1952-4422-a481-9faddbca9a41
DTSTAMP:20250617T153826
DTSTART:20251113T120000
DTEND:20251113T130000
SUMMARY:FS 1.20 Body compartments and biological barriers 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:46306ad1-581a-49a6-b392-5a315de898ce
DTSTAMP:20250617T153826
DTSTART:20251113T140000
DTEND:20251113T150000
SUMMARY:DS 1.5 Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:a287eefb-b37a-478d-ac46-f6577b9d6c88
DTSTAMP:20250617T153826
DTSTART:20251113T150000
DTEND:20251113T160000
SUMMARY:DS Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:5ab4a1b5-72ad-446f-a0ee-309bcebb2392
DTSTAMP:20250617T153826
DTSTART:20251113T160000
DTEND:20251113T170000
SUMMARY:DS  Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:b789d083-baa7-4f46-844e-16305caf4202
DTSTAMP:20250617T153826
DTSTART:20251114T100000
DTEND:20251114T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:fdd0c585-df08-487b-8722-174a37ba90b1
DTSTAMP:20250617T153826
DTSTART:20251114T110000
DTEND:20251114T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:12a9aa23-7c0b-450e-8d8c-70aae5b058c8
DTSTAMP:20250617T153826
DTSTART:20251114T120000
DTEND:20251114T130000
SUMMARY:Comms Wellbeing - looking after ourselves
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2b7e5dc7-feac-4323-a69c-37393f41e618
DTSTAMP:20250617T153826
DTSTART:20251114T140000
DTEND:20251114T150000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:b22666bb-42cb-42e6-bb12-503048aa00b6
DTSTAMP:20250617T153826
DTSTART:20251114T150000
DTEND:20251114T160000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:5776e706-af58-4974-9d44-7cc7ce14c681
DTSTAMP:20250617T153826
DTSTART:20251117T100000
DTEND:20251117T110000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0389f61d-a1f5-4e28-b418-41dd971c192f
DTSTAMP:20250617T153826
DTSTART:20251117T110000
DTEND:20251117T120000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a435f863-d7a2-4430-a3b7-eb23ad4243e5
DTSTAMP:20250617T153826
DTSTART:20251117T120000
DTEND:20251117T130000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f6701470-1382-40f3-a95c-9b92448d8a40
DTSTAMP:20250617T153826
DTSTART:20251117T140000
DTEND:20251117T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6ea4fe66-73f8-4709-b60d-eb95a3f2eb28
DTSTAMP:20250617T153826
DTSTART:20251117T150000
DTEND:20251117T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:56979e3f-1696-4a28-9a8d-c953e3391f4f
DTSTAMP:20250617T153826
DTSTART:20251118T140000
DTEND:20251118T150000
SUMMARY:Skills Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:df5c95d1-57e3-4e5e-951f-0745156dee26
DTSTAMP:20250617T153826
DTSTART:20251118T150000
DTEND:20251118T160000
SUMMARY:Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:946b61fb-bf54-4555-b390-e3e82c017f02
DTSTAMP:20250617T153826
DTSTART:20251119T100000
DTEND:20251119T110000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:00fdfc99-b074-42e2-a6bf-f3b6b60d0e08
DTSTAMP:20250617T153826
DTSTART:20251119T110000
DTEND:20251119T120000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:702a2ce3-824b-4419-a5e4-eaa7929e1c87
DTSTAMP:20250617T153826
DTSTART:20251120T100000
DTEND:20251120T110000
SUMMARY:FS 1.21 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:65e6ae85-c7dd-48ae-b839-845450366ba8
DTSTAMP:20250617T153826
DTSTART:20251120T110000
DTEND:20251120T120000
SUMMARY:FS 1.22 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:dabed30c-c15a-40c1-bec3-3f7ff48af3ba
DTSTAMP:20250617T153826
DTSTART:20251120T120000
DTEND:20251120T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:a7b741c3-f90f-41e9-8333-162de7ad4a37
DTSTAMP:20250617T153826
DTSTART:20251120T140000
DTEND:20251120T150000
SUMMARY:DS term 1 - pulling it all together
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:a2f1dd2e-e929-423e-bcec-f9761f1ad22d
DTSTAMP:20250617T153826
DTSTART:20251120T150000
DTEND:20251120T160000
SUMMARY:DS Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:fb3f671a-c168-4000-84bf-08efdd6374ae
DTSTAMP:20250617T153826
DTSTART:20251120T160000
DTEND:20251120T170000
SUMMARY:DS  Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:de771e25-bb45-4803-a67a-cb2e4d1d6d1e
DTSTAMP:20250617T153826
DTSTART:20251121T110000
DTEND:20251121T120000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:87e2743f-d6ce-4876-a93c-f8c6f803d452
DTSTAMP:20250617T153826
DTSTART:20251121T120000
DTEND:20251121T130000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:fc631552-c1ac-4966-b7bb-44b1367d8a42
DTSTAMP:20250617T153826
DTSTART:20251121T140000
DTEND:20251121T150000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:65328f9e-79c3-4594-b6d1-6ce6c99cbf4d
DTSTAMP:20250617T153826
DTSTART:20251121T150000
DTEND:20251121T160000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:153a5179-8c18-44b0-b59c-9468477595f5
DTSTAMP:20250617T153826
DTSTART:20251124T100000
DTEND:20251124T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7c58d757-65e1-43d1-a455-1b500ce32c82
DTSTAMP:20250617T153826
DTSTART:20251124T110000
DTEND:20251124T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9cde28f9-0dd2-431e-aebe-2c2649f921c2
DTSTAMP:20250617T153826
DTSTART:20251124T120000
DTEND:20251124T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5cb1fe1a-d375-47f8-8b13-e9085f1689ce
DTSTAMP:20250617T153826
DTSTART:20251124T140000
DTEND:20251124T150000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:77c74d0a-212e-4be9-84a2-5ef61c989de0
DTSTAMP:20250617T153826
DTSTART:20251124T150000
DTEND:20251124T160000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:590620ba-fd35-4bb3-ad4c-cec1740c2613
DTSTAMP:20250617T153826
DTSTART:20251124T160000
DTEND:20251124T170000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fe0d9569-826e-4e49-ad70-71cf4caf07d4
DTSTAMP:20250617T153826
DTSTART:20251125T110000
DTEND:20251125T120000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:30310220-95e6-4ec0-9f59-d786e781c299
DTSTAMP:20250617T153826
DTSTART:20251125T120000
DTEND:20251125T130000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:4477d717-4aea-49df-8a28-669415857d5e
DTSTAMP:20250617T153826
DTSTART:20251126T100000
DTEND:20251126T110000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7c06d007-2a34-4d30-94ff-c4a507fd73c1
DTSTAMP:20250617T153826
DTSTART:20251126T110000
DTEND:20251126T120000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:16279bb0-782b-4014-86e3-44779d7e4706
DTSTAMP:20250617T153826
DTSTART:20251127T110000
DTEND:20251127T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:4e3dc547-37a6-475b-adcb-1bfdb6e7e6ec
DTSTAMP:20250617T153826
DTSTART:20251127T120000
DTEND:20251127T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:7fcc40d4-facb-41f2-99e7-f9d2070b2b46
DTSTAMP:20250617T153826
DTSTART:20251127T140000
DTEND:20251127T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:00f60b81-fd09-415d-99c8-209c8e0e0a0c
DTSTAMP:20250617T153826
DTSTART:20251127T150000
DTEND:20251127T160000
SUMMARY:FS Joint workshop with pharmacokinetics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:b47413fd-093a-4554-8ec3-f8fe612642ad
DTSTAMP:20250617T153826
DTSTART:20251128T110000
DTEND:20251128T120000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:d21fdfa4-51ec-44ef-8afc-1d8c3cbff939
DTSTAMP:20250617T153826
DTSTART:20251128T120000
DTEND:20251128T130000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:0eed1b7f-9bb7-452f-ae67-05f48df6409d
DTSTAMP:20250617T153826
DTSTART:20251128T140000
DTEND:20251128T150000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:cfcc2a6d-463f-43a3-8470-0c2ebafd0677
DTSTAMP:20250617T153826
DTSTART:20251128T150000
DTEND:20251128T160000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:0a77fe50-0b4d-4929-9432-9075de3a45dc
DTSTAMP:20250617T153826
DTSTART:20251208T140000
DTEND:20251208T150000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ec356055-8b85-4d66-9305-ea17a0f70eb1
DTSTAMP:20250617T153826
DTSTART:20251208T150000
DTEND:20251208T160000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b03bb917-53f5-4606-8326-847baae78b3d
DTSTAMP:20250617T153826
DTSTART:20251208T160000
DTEND:20251208T170000
SUMMARY:Christmas social
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:fa91a5f6-58ef-4eb0-9d09-182801ef7020
DTSTAMP:20250617T153826
DTSTART:20260105T100000
DTEND:20260105T110000
SUMMARY:HUB NB Need computer lab too for Assess BQ1 resits
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0ac4f36f-656d-463d-9efc-9f8cdd8bf333
DTSTAMP:20250617T153826
DTSTART:20260105T110000
DTEND:20260105T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1256ff41-47cb-4de0-a662-a3df82568ada
DTSTAMP:20250617T153826
DTSTART:20260105T120000
DTEND:20260105T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:24f1b99f-10e9-4e9e-aac3-5f26b62bd3b2
DTSTAMP:20250617T153826
DTSTART:20260105T140000
DTEND:20260105T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:2d547337-103a-4616-9a15-ee053ff900a4
DTSTAMP:20250617T153826
DTSTART:20260105T150000
DTEND:20260105T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:b8a72ad8-349e-4c1b-97fb-d5fee69d4db9
DTSTAMP:20250617T153826
DTSTART:20260106T110000
DTEND:20260106T120000
SUMMARY:FS 1.27 Immunity 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8082dd61-a3a0-4a21-9da3-0231e306e4f7
DTSTAMP:20250617T153826
DTSTART:20260106T120000
DTEND:20260106T130000
SUMMARY:FS 1.28 Immunity 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:22ada65c-157b-4c93-b483-a49e35aaff70
DTSTAMP:20250617T153826
DTSTART:20260108T100000
DTEND:20260108T110000
SUMMARY:Comms Course director/year lead check in 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:be9ebe12-4c2c-4ac5-84b0-368eb5a0bf6a
DTSTAMP:20250617T153826
DTSTART:20260108T110000
DTEND:20260108T120000
SUMMARY:FS 1.29 Structure and function of blood
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c6d40997-7201-4687-bf1a-8e48f75e51f2
DTSTAMP:20250617T153826
DTSTART:20260108T120000
DTEND:20260108T130000
SUMMARY:FS 1.30 Blood disorders
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:0a5e8749-9c8e-4d4d-b6a9-5fc89a343f55
DTSTAMP:20250617T153826
DTSTART:20260108T140000
DTEND:20260108T150000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:af27b428-f2ea-4cc3-8a02-6e51eddd1879
DTSTAMP:20250617T153826
DTSTART:20260108T150000
DTEND:20260108T160000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:beda66b8-3ff0-40d3-8f85-356a41c96087
DTSTAMP:20250617T153826
DTSTART:20260108T160000
DTEND:20260108T170000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:d1c14999-de6f-4376-9db5-8d7fedafa468
DTSTAMP:20250617T153826
DTSTART:20260109T100000
DTEND:20260109T110000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:c5df6052-a943-4edb-8368-b4a05058acea
DTSTAMP:20250617T153826
DTSTART:20260109T110000
DTEND:20260109T120000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:bb02bd14-7c7a-493e-ac60-f0ce0705efcf
DTSTAMP:20250617T153826
DTSTART:20260109T120000
DTEND:20260109T130000
SUMMARY:DD Briefing on handling biological samples (urine) for aspirin practical
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:8728e64f-e9d7-458e-ae28-e29441b0a08a
DTSTAMP:20250617T153826
DTSTART:20260109T140000
DTEND:20260109T150000
SUMMARY:PD 2.13 Anti-platelet and fibrinolytic agents
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:2d510fed-4dbb-4405-a176-a1788a2ff82e
DTSTAMP:20250617T153826
DTSTART:20260109T150000
DTEND:20260109T160000
SUMMARY:DH 2.9 Platelets as drug targets - arterial thrombosis
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:4c1110f7-4cca-4652-914b-ead8d62596b2
DTSTAMP:20250617T153826
DTSTART:20260112T100000
DTEND:20260112T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ada618be-4d40-40c0-a91a-e1753a979fb1
DTSTAMP:20250617T153826
DTSTART:20260112T110000
DTEND:20260112T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a4d570dc-39d8-4737-8924-10a5945ed1d4
DTSTAMP:20250617T153826
DTSTART:20260112T120000
DTEND:20260112T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:26fdd65b-ca11-4968-903b-45319e7a0886
DTSTAMP:20250617T153826
DTSTART:20260112T140000
DTEND:20260112T150000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b8c94ee0-6656-4413-8a1d-9476bfa354dd
DTSTAMP:20250617T153826
DTSTART:20260112T150000
DTEND:20260112T160000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d5e29175-7f46-4b8b-bc63-ef2e95d4268d
DTSTAMP:20250617T153826
DTSTART:20260112T160000
DTEND:20260112T170000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cd3dedfa-076d-4acf-8584-ba43a302cd01
DTSTAMP:20250617T153826
DTSTART:20260113T120000
DTEND:20260113T130000
SUMMARY:Skills Writing up the aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c3424b33-e1e8-48f4-9f1b-d25e5b689b99
DTSTAMP:20250617T153826
DTSTART:20260113T140000
DTEND:20260113T150000
SUMMARY:FS 2.14  Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:ac4d15c4-cff6-4334-80a8-2169dc4b8063
DTSTAMP:20250617T153826
DTSTART:20260113T150000
DTEND:20260113T160000
SUMMARY:FS 2.15 Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:fa657b5c-c175-4868-84d5-c8df11af3a6b
DTSTAMP:20250617T153826
DTSTART:20260115T100000
DTEND:20260115T110000
SUMMARY:Comms - introduction to literature searching
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4b6f54f8-6564-48fd-89b8-a6aba92051b8
DTSTAMP:20250617T153826
DTSTART:20260115T110000
DTEND:20260115T120000
SUMMARY:PD 2.14  Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:26d1d40c-d64c-4499-a9f2-2952bcf0c925
DTSTAMP:20250617T153826
DTSTART:20260115T120000
DTEND:20260115T130000
SUMMARY:PD 2.15 Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:9ee79b3a-ddf1-4264-be77-562832299e51
DTSTAMP:20250617T153826
DTSTART:20260115T140000
DTEND:20260115T150000
SUMMARY:DH 1.6 How is the NHS structured?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:06251268-47ac-4c8c-a4da-4c4576209d6f
DTSTAMP:20250617T153826
DTSTART:20260115T150000
DTEND:20260115T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:eeae3e67-8311-434a-b5c0-ae0ea75fb7d9
DTSTAMP:20250617T153826
DTSTART:20260116T100000
DTEND:20260116T110000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:b19bb832-c28c-46f2-9be0-050e3fd0dcb3
DTSTAMP:20250617T153826
DTSTART:20260116T110000
DTEND:20260116T120000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:4f97f820-f6fc-42e6-ba33-b2a7b9b0d05f
DTSTAMP:20250617T153826
DTSTART:20260116T120000
DTEND:20260116T130000
SUMMARY:DS  Aspirin practical analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:ef4bb2d8-acb9-4c9c-b263-5fdbbf63ad49
DTSTAMP:20250617T153826
DTSTART:20260116T140000
DTEND:20260116T150000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7a50c08c-52e2-45a8-9e32-61bfabacd583
DTSTAMP:20250617T153826
DTSTART:20260116T150000
DTEND:20260116T160000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:bbe48288-47c5-4d9a-b490-8334ce59886a
DTSTAMP:20250617T153826
DTSTART:20260119T100000
DTEND:20260119T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a3698906-6197-481f-87ad-a9ccb57172c8
DTSTAMP:20250617T153826
DTSTART:20260119T110000
DTEND:20260119T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d327ff03-4f44-4f2d-a56b-3c16cb52af5e
DTSTAMP:20250617T153826
DTSTART:20260119T120000
DTEND:20260119T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:016f7d45-9d55-4020-9995-32eb8298b4f1
DTSTAMP:20250617T153826
DTSTART:20260119T140000
DTEND:20260119T150000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2ddecb5e-e23b-4374-8577-64e2d5a1d5a0
DTSTAMP:20250617T153826
DTSTART:20260119T150000
DTEND:20260119T160000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ba456c28-8874-45e8-8d26-1c6cc50cf504
DTSTAMP:20250617T153826
DTSTART:20260120T100000
DTEND:20260120T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ed141bca-d865-4519-9948-d4157e989ba6
DTSTAMP:20250617T153826
DTSTART:20260120T110000
DTEND:20260120T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9cbf767e-7062-4925-a51a-722f7c5755de
DTSTAMP:20250617T153826
DTSTART:20260120T120000
DTEND:20260120T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2bcd1392-8b4d-4e01-86c3-275ba9e367aa
DTSTAMP:20250617T153826
DTSTART:20260120T130000
DTEND:20260120T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0612235e-05f3-4575-8cfd-247ae5747ec9
DTSTAMP:20250617T153826
DTSTART:20260120T140000
DTEND:20260120T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4de98a4d-64f9-4010-b468-1a267f9e7ba2
DTSTAMP:20250617T153826
DTSTART:20260120T150000
DTEND:20260120T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2ab171ec-6602-402b-a024-90b73ad179f1
DTSTAMP:20250617T153826
DTSTART:20260120T160000
DTEND:20260120T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:60bed411-80e1-481d-b2e9-bcd9874d97de
DTSTAMP:20250617T153826
DTSTART:20260121T100000
DTEND:20260121T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cbdc8ffb-2720-4688-a2f6-6c92d9ea860e
DTSTAMP:20250617T153826
DTSTART:20260121T110000
DTEND:20260121T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3f4a74e2-b4bf-444a-81ba-037dc301c844
DTSTAMP:20250617T153826
DTSTART:20260121T120000
DTEND:20260121T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d1729f74-6f69-4b86-8638-a68052f6c2e3
DTSTAMP:20250617T153826
DTSTART:20260121T130000
DTEND:20260121T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3c6d75c8-a544-4864-8f37-bcff4139d76c
DTSTAMP:20250617T153826
DTSTART:20260121T140000
DTEND:20260121T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d20f0f97-b3b5-470c-ab24-1b9680ed1d9c
DTSTAMP:20250617T153826
DTSTART:20260121T150000
DTEND:20260121T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8a6bb343-63b6-416a-9992-52afcd0f10eb
DTSTAMP:20250617T153826
DTSTART:20260121T160000
DTEND:20260121T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:eb9cfd23-55b7-42b1-96ef-97042eb22ebc
DTSTAMP:20250617T153826
DTSTART:20260122T100000
DTEND:20260122T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2563a3c3-7678-48a9-9ea1-8d8b62438934
DTSTAMP:20250617T153826
DTSTART:20260122T110000
DTEND:20260122T120000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:38159324-ab84-45d6-9845-7d720e395cd1
DTSTAMP:20250617T153826
DTSTART:20260122T120000
DTEND:20260122T130000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f562506d-a1db-4794-bdef-ad9f1dff4270
DTSTAMP:20250617T153826
DTSTART:20260122T140000
DTEND:20260122T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0d64db55-c5ea-404e-a803-3585b35282da
DTSTAMP:20250617T153826
DTSTART:20260122T150000
DTEND:20260122T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ce9685ea-bb07-4184-9a1b-f57f4d80bdf5
DTSTAMP:20250617T153826
DTSTART:20260122T160000
DTEND:20260122T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ac14c07d-5f68-421a-9452-7faeebaa2068
DTSTAMP:20250617T153826
DTSTART:20260123T100000
DTEND:20260123T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b0050f94-491e-4a36-8711-e739099a8c53
DTSTAMP:20250617T153826
DTSTART:20260123T110000
DTEND:20260123T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:bed4c2c4-7135-40d5-b479-c5e9574782e5
DTSTAMP:20250617T153826
DTSTART:20260123T120000
DTEND:20260123T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:250342eb-73fe-484d-afe0-448ab4c28804
DTSTAMP:20250617T153826
DTSTART:20260123T130000
DTEND:20260123T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:aa6d7b5b-f2aa-41c9-a28d-392aa7a77a84
DTSTAMP:20250617T153826
DTSTART:20260123T140000
DTEND:20260123T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:20915462-3e53-4a11-b0d0-b431ca3792b1
DTSTAMP:20250617T153826
DTSTART:20260123T150000
DTEND:20260123T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e875383f-75fa-4f87-a79e-887d3f967309
DTSTAMP:20250617T153826
DTSTART:20260123T160000
DTEND:20260123T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:57e4b077-684c-4014-bea2-b7a0a6a18214
DTSTAMP:20250617T153826
DTSTART:20260129T140000
DTEND:20260129T150000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b62c0718-7a51-432d-9841-92bdffefef93
DTSTAMP:20250617T153826
DTSTART:20260129T150000
DTEND:20260129T160000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ce8e433d-d848-4b32-b875-30bc1b1b8293
DTSTAMP:20250617T153826
DTSTART:20260129T160000
DTEND:20260129T170000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3f07b2e0-cdb4-482f-8b2b-d36d8f8f8f2b
DTSTAMP:20250617T153826
DTSTART:20260130T100000
DTEND:20260130T110000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dce9ce6a-41a5-44fa-9fcd-8517c0a2674c
DTSTAMP:20250617T153826
DTSTART:20260130T110000
DTEND:20260130T120000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e41ef952-d2bf-4d7f-8bb6-e673f9915581
DTSTAMP:20250617T153826
DTSTART:20260130T120000
DTEND:20260130T130000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cbcee254-65b5-43d5-8d4d-97d4dfbf35e0
DTSTAMP:20250617T153826
DTSTART:20260130T140000
DTEND:20260130T150000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f8db063f-60b6-49c3-a23f-1f0c4eed3222
DTSTAMP:20250617T153826
DTSTART:20260130T150000
DTEND:20260130T160000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0b7a5587-53d8-4f03-adc4-5db5e07db5d1
DTSTAMP:20250617T153826
DTSTART:20260130T160000
DTEND:20260130T170000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
END:VCALENDAR
